Role of Blood Groups in Risk, Severity, Prognosis, and Response to Treatment of the Diseases
Abstract
Between the end of the last century and the initiation of this one, blood groups and their importance have been increasingly assessed and reported about. In addition to scientific investigations, popular curiosity is also increasing. Most of the investigation is based on phenotypic divisions of blood groups and primarily associated with the ABO system. This is the most significant blood group system in transfusion and transplantation medicine, as it represents an immunological barrier against incompatible blood transfusions or transplantation of incompatible tissues. The clinical significance of antibodies to the ABO system is due to the natural presence of such antibodies and their high function, which can be the reason for hemolytic transfusion reactions, hemolytic disease of the newborn and rejection of the transplanted tissues. The frequency of ABO alleles in different populations is not the same, and many investigations have reported an association between the occurrence of some disorders with different genotypes of ABO blood groups.
References
Hamed IA, Mandal AK, Parker D, Czerwinski AW, Mask DR, Wenzl JE. ABO blood groups and renal disease. Ann Clin Lab Sci. 1979;9(6):524-6.
Ray DS, Thukral S. ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report. Am J Case Rep. 2017;18:1073-6.
Levine MN, Kuhns WK, Bolk TA, Beyer TA, Rosse WF. Acquired alteration in the expression of blood groups in a patient with sideroblastic anemia and chronic renal failure. Transfusion. 1984;24(1):8-12.
Etheredge EE, Bettonville P, Sicard GA, Anderson CB. Anti-erythrocyte antibodies, leukocytotoxins and human renal allograft survival. Tissue Antigens. 1982;19(3):205-12.
Heydenreich G, Pindborg T, Schmidt H. Bullous dermatosis among patients with chronic renal failure of high dose frusemide. Acta Med Scand. 1977;202(1-2):61-4.
Gallegos-Orozco JF, Kim R, Thiesset HF, Hatch J, Lynch K, Chaly T, Jr., et al. Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation. Cureus. 2016;8(11):e890.
Omae K, Fukuma S, Ikenoue T, Kondo T, Takagi T, Ishihara H, et al. Effect of ABO blood type on the outcomes of patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. Urol Oncol. 2017;35(9):540.e7-.e12.
Wafa EW, Shokeir AA, Akl A, Hassan N, Fouda MA, El Dahshan K, et al. Effect of donor and recipient variables on the long-term live-donor renal allograft survival in children. Arab J Urol. 2011;9(2):85-91.
Abou-Jaoude MM, Nawfal N, Najm R, Honeidi M, Shaheen J, Almawi WY. Effect of pretransplantation hemoglobin blood concentration on renal allograft survival and function. Transplant Proc. 2010;42(3):760-2.
Shamsa A, Motavalli SM, Aghdam B. Erectile function in end-stage renal disease before and after renal transplantation. Transplant Proc. 2005;37(7):3087-9.
Arslan B, Gürkan O, Çetin B, Arslan Ö A, Göv T, Yazıcı G, et al. Evaluation of ABO blood groups and blood-based biomarkers as a predictor of growth kinetics of renal angiomyolipoma. Int Urol Nephrol. 2018;50(12):2131-7.
Shahdadi H, Balouchi A, Sepehri Z, Rafiemanesh H, Magbri A, Keikhaie F, et al. Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease. Glob J Health Sci. 2016;8(8):55781.
Shimizu T, Tanabe K, Tokumoto T, Shimmura H, Ishikawa N, Ishida H, et al. Histological features of renal allograft biopsies in ABO minor-mismatched kidney transplantation. Clin Transplant. 2003;17 Suppl 10:9-13.
Trébern-Launay K, Kessler M, Bayat-Makoei S, Quérard AH, Briançon S, Giral M, et al. Horizontal mixture model for competing risks: a method used in waitlisted renal transplant candidates. Eur J Epidemiol. 2018;33(3):275-86.
Ward FE, MacQueen JM. Immunogenetic factors that may contribute to ethnic differences in renal allograft survival. Clin Transplant. 1996;10(6 Pt 2):620-4.
Hassan AA, Amin EM, Amer AI, Omar EL, Aly MH. The impact of non-HLA factors on renal graft survival. Saudi J Kidney Dis Transpl. 1994;5(3):359-64.
Lammerts RGM, Lagendijk LM, Tiller G, Dam WA, Lancaster HL, Daha MR, et al. Machine-perfused donor kidneys as a source of human renal endothelial cells. Am J Physiol Renal Physiol. 2021;320(5):F947-f62.
Jeon HJ, Bae HJ, Ham YR, Choi DE, Na KR, Ahn MS, et al. Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study. Kidney Res Clin Pract. 2019;38(1):116-23.
Worsley CM, Mayne ES. Patients Awaiting Renal Transplantation in South Africa: The Need for Highly Sensitive Laboratory Testing and Immunological Risk Stratification. Clin Lab. 2018;64(10):1649-54.
Moghal NE, Milford DV, Hulton SA, Taylor CM. The prevalence and treatment of end-stage renal disease in an Asian child population. Nephrol Dial Transplant. 1997;12(12):2517-20.
Barth DA, Sareban N, Lindner AK, Daller LAJ, Matzhold EM, Hutterer G, et al. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up. Urol Oncol. 2021;39(10):736.e9-.e16.
Mangal AK, Logan D, Sinclair M, Stillwell G. Protection against hemolysis in ABO mismatched renal transplantation. Transfusion. 1984;24(4):363-4.
Collins AB, Chicano SL, Cornell LD, Tolkoff-Rubin N, Goes NB, Saidman SL, et al. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts. Transplant Proc. 2006;38(10):3427-9.
Giannopoulos A, Kostakopoulos A, Sofras F, Kyriakidis A, Pantazopoulos D. Relation of ABO and RH blood groups with renal cell carcinoma. Acta Urol Belg. 1985;53(1):29-31.
Slapak M, Naik RB, Lee HA. Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis. Transplantation. 1981;31(1):4-7.
Alkhunaizi AM, de Mattos AM, Barry JM, Bennett WM, Norman DJ. Renal transplantation across the ABO barrier using A2 kidneys. Transplantation. 1999;67(10):1319-24.
Koka P, Cecka JM. Sensitization and crossmatching in renal transplantation. Clin Transpl. 1989:379-90.
Pruthi R, Hilton R, Pankhurst L, Mamode N, Hudson A, Roderick P, et al. UK Renal Registry 16th annual report: chapter 4 demography of patients waitlisted for renal transplantation in the UK: national and centre-specific analyses. Nephron Clin Pract. 2013;125(1-4):81-98.
Rai S, Saronwala KC, Singh R. ABO blood groups in cancer of the gastro-intestinal tract. Indian J Cancer. 1972;9(1):97-100.
Bayan K, Tüzün Y, Yilmaz S, Dursun M, Canoruc F. Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding. Dig Dis Sci. 2009;54(5):1029-34.
Pena AS, Biemond I. HLA, blood groups and gastrointestinal diseases. Acta Gastroenterol Belg. 1984;47(2):136.
Ürün Y, Utkan G, Yalcin Ş, Coşkun H, Koçer M, Özdemir NY, et al. Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal stromal tumors: Turkish Oncology Group. Asian Pac J Cancer Prev. 2012;13(8):4129-31.
Seyda T, Derya C, Füsun A, Meliha K. The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey. Helicobacter. 2007;12(3):244-50.
Gampa A, Engen PA, Shobar R, Mutlu EA. Relationships between gastrointestinal microbiota and blood group antigens. Physiol Genomics. 2017;49(9):473-83.
Hermans MP, Ahn SA, Rousseau MF. What is the phenotype of patients with gastrointestinal intolerance to metformin? Diabetes Metab. 2013;39(4):322-9.
Zhong GC, Liu S, Wu YL, Xia M, Zhu JX, Hao FB, et al. ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population. PloS one. 2019;14(12):e0225792.
Barone M, Avolio AW, Di Leo A, Burra P, Francavilla A. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption. Transplantation. 2008;85(6):844-9.
Lu LL, Zhang YH, Yao MH, Lu JH, Chen YS, Xu J, et al. ABO blood groups and liver cancer: prospective results from an HBsAg cohort study. BMJ Open. 2021;11(5):e044039.
Park MS, Lee KW, You T, Suh SW, Kim H, Choi Y, et al. The "ABO cross-transplantation problem" in liver transplantation in Korea. Transplant Proc. 2013;45(8):2878-9.
Martino RB, Waisberg DR, Dias APM, Inoue VBS, Arantes RM, Haddad LBP, et al. Access to Liver Transplantation in Different ABO-Blood Groups and "Exceptions Points" in a Model for End-Stage Liver Disease Allocation System: A Brazilian Single-Center Study. Transplant Proc. 2018;50(3):754-7.
Tao B, Yang M, Chen H, Pan H, Liu W, Yi H, et al. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population. J Clin Pharm Ther. 2020;45(4):638-45.
Shavakhi A, Hajalikhani M, Minakari M, Norian A, Riahi R, Azarnia M, et al. The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection. J Res Med Sci. 2012;17(5):466-9.
Sharma H, Tun-Abraham ME, McAlister V. Bidirectional graft-host hematological traffic in liver transplantation. Hepatobiliary Surg Nutr. 2019;8(3):253-7.
Tiwari AK, Pandey P, Aggarwal G, Dara RC, Rawat G, Raina V, et al. Cascade plasmapheresis (CP) as a preconditioning regime in ABO-incompatible live related donor liver transplants (ABOi-LDLT). Transplant Res. 2014;3:17.
Ha HS, Hong JJ, Kim IO, Lee SR, Lee AY, Ha TY, et al. Deceased donor liver transplantation under the Korean model for end-stage liver disease score-based liver allocation system: 2-year allocation results at a high-volume transplantation center. Korean J Transplant. 2019;33(4):112-7.
AJ IJ, van der Hilst CS, Nijkamp DM, Bottema JT, Fidler V, Porte RJ, et al. Does the meld system provide equal access to liver transplantation for patients with different ABO blood groups? Transpl Int. 2016;29(8):883-9.
Hong Z, Smart G, Dawood M, Kaita K, Wen SW, Gomes J, et al. Hepatitis C infection and survivals of liver transplant patients in Canada, 1997-2003. Transplant Proc. 2008;40(5):1466-70.
Ooi K, Shiraki K, Morishita Y, Nobori T. High-molecular intestinal alkaline phosphatase in chronic liver diseases. J Clin Lab Anal. 2007;21(3):133-9.
Al-Hamoudi W, Abaalkhail F, Bendahmash A, Allam N, Hegab B, Elsheikh Y, et al. The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool. Hepatol Int. 2016;10(2):347-54.
Marín-Gómez LM, Bernal-Bellido C, Alamo-Martínez JM, Porras-López FM, Suárez-Artacho G, Serrano-Diaz-Canedo J, et al. Intraoperative hepatic artery blood flow predicts early hepatic artery thrombosis after liver transplantation. Transplant Proc. 2012;44(7):2078-81.
Busquets J, Castellote J, Torras J, Fabregat J, Ramos E, Llado L, et al. Liver transplantation across Rh blood group barriers increases the risk of biliary complications. J Gastrointest Surg. 2007;11(4):458-63.
Zhu JJ, Xia Q, Zhang JJ, Xue F, Chen XS, Li QG, et al. Living donor liver transplantation in 43 children with biliary atresia: a single-center experience from the mainland of China. Hepatobiliary Pancreat Dis Int. 2012;11(3):250-5.
Olivier E, Qiu C, Bouhassira EE. Novel, high-yield red blood cell production methods from CD34-positive cells derived from human embryonic stem, yolk sac, fetal liver, cord blood, and peripheral blood. Stem Cells Transl Med. 2012;1(8):604-14.
Rocha C, Perera MT, Roberts K, Bonney G, Gunson B, Nightingale P, et al. Outcomes after liver transplantation of patients with Indo-Asian ethnicity. Transplantation. 2015;99(4):860-6.
Chaib E, Fridman C, Massad E. Potential effect of using ABO-compatible living-donor liver transplantation. Transplant Proc. 2009;41(9):3775-8.
Ge J, Roberts JP, Lai JC. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States. Clin Transplant. 2017;31(8).
Hori T, Kirino I, Uemoto S. Right posterior segment graft in living donor liver transplantation. Hepatol Res. 2015;45(11):1076-82.
Monfort M, Honoré P, Gothot A, Gérard C. Simultaneous passenger lymphocyte syndrome and multiple alloimmunization against donor's blood group antigens after liver transplantation. Vox Sang. 2015;109(1):86-90.
Nesher E, Island E, Tryphonopoulos P, Moon J, Nishida S, Selvaggi G, et al. Split liver transplantation. Transplant Proc. 2011;43(5):1736-41.
Jung BH, Hwang S, Song GW, Jung DH, Ha TY, Park GC, et al. Updated status of deceased-donor liver graft allocation for high-urgency adult patients in a Korean high-volume liver transplantation center. Transplant Proc. 2015;47(3):580-3.
Soin AS, Raut V, Mohanka R, Rastogi A, Goja S, Balachandran M, et al. Use of ABO-incompatible grafts in living donor liver transplantation--first report from India. Indian J Gastroenterol. 2014;33(1):72-6.
Hosaagrahara Ramakrishna S, Kasala MB, Perumal K, Malleeswaran S, Patcha RV, Varghese J, et al. When Push Comes to Shove! Emergency ABO-Incompatible Pediatric Living Donor Liver Transplant for Acute Wilson's Disease. J Clin Exp Hepatol. 2022;12(2):658-63.
Najim Al-Din AS, Kurdi A, Mubaidin A, El-Khateeb M, Khalil RW, Wriekat AL. Epidemiology of multiple sclerosis in Arabs in Jordan: a comparative study between Jordanians and Palestinians. J Neurol Sci. 1996;135(2):162-7.
Airas L, Saraste M, Rinta S, Elovaara I, Huang YH, Wiendl H. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin Exp Immunol. 2008;151(2):235-43.
Roberts DF, Papiha SS, Poskanzer DC. Polymorphisms and multiple sclerosis in Orkney. J Epidemiol Community Health. 1979;33(4):236-42.
Alexander KS, Zakai NA, Gillett S, McClure LA, Wadley V, Unverzagt F, et al. ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort. Neurology. 2014;83(14):1271-6.
Li J, Zhou J, Wan Y, Liu L, Ou C. Association Between ABO Blood Type and Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Unilateral Total Hip Arthroplasty Surgery in China. Med Sci Monit. 2017;23:2584-9.
Foley D, Hay DA, Mitchell RJ. Specific cognitive effects of mild iron deficiency and associations with blood polymorphisms in young adults. Ann Hum Biol. 1986;13(5):417-25.
Pisk SV, Vuk T, Ivezić E, Jukić I, Bingulac-Popović J, Filipčić I. ABO blood groups and psychiatric disorders: a Croatian study. Blood Transfus. 2019;17(1):66-71.
Flemenbaum A, Larson JW. ABO-RH blood groups and psychiatric diagnosis: a critical review. Dis Nerv Syst. 1976;37(10):581-3.
Goldin LR, Gershon ES. Association and linkage studies of genetic marker loci in major psychiatric disorders. Psychiatr Dev. 1983;1(4):387-418.
Rafaelsen OJ, Shapiro RW. Psychopharmacological studies in genetically determined subgroups of psychiatric patients. Prog Neuropsychopharmacol. 1979;3(1-3):147-54.
Welsby IJ, Phillips-Bute B, Mathew JP, Newman MF, Becker R, Rao S, et al. ABO blood group influences transfusion and survival after cardiac surgery. J Thromb Thrombolysis. 2014;38(3):402-8.
Hansen SM, Sprogøe U, Möller S, Andersen C. ABO blood group is related to bleeding in cardiac surgery. Acta Anaesthesiol Scand. 2020.
Platt D, Mühlberg W, Kiehl L, Schmitt-Rüth R. ABO blood group system, age, sex, risk factors and cardiac infarction. Arch Gerontol Geriatr. 1985;4(3):241-9.
Irving CA, Gennery AR, Carter V, Wallis JP, Hasan A, Griselli M, et al. ABO-incompatible cardiac transplantation in pediatric patients with high isohemagglutinin titers. J Heart Lung Transplant. 2015;34(8):1095-102.
Blumberg N, Heal JM. ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgery. Transfusion. 2002;42(11):1527-8; author reply 8-9.
Kheradmand F, Rasmi Y, Nemati M, Mohammadzad MH. ABO-Rh blood groups distribution in cardiac syndrome X patients. J Cardiovasc Dis Res. 2012;3(3):197-9.
Pikul FJ, Bolman RM, Saffitz JE, Chaplin H. Anti-B-mediated rejection of an ABO-incompatible cardiac allograft despite aggressive plasma exchange transfusion. Transplant Proc. 1987;19(6):4601-4.
Blumberg N, Heal JM, Hicks GL, Jr., Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion. 2001;41(6):790-3.
Cooper DK, Human PA, Rose AG, Rees J, Keraan M, DuToit E, et al. Can cardiac allografts and xenografts be transplanted across the ABO blood group barrier? Transplant Proc. 1989;21(1 Pt 1):549-50.
Cooper DK, Lexer G, Rose AG, Rees J, Keraan M, Du Toit E, et al. Cardiac allograft survival in ABO blood group incompatible baboons. Transplant Proc. 1987;19(1 Pt 2):1036-8.
Ye Y, Niekrasz M, Kehoe M, Rolf LL, Jr., Martin M, Baker J, et al. Cardiac allotransplantation across the ABO-blood group barrier by the neutralization of preformed antibodies: the baboon as a model for the human. Lab Anim Sci. 1994;44(2):121-4.
Albrechtsen D, Geiran O, Foerster A, Fauchald P, Flesland O, Lindberg H, et al. Cardiac transplantation from a blood group ABO-incompatible donor: a case report. Transplant Proc. 1990;22(1):143.
Taghavi S, Jayarajan SN, Wilson LM, Komaroff E, Mangi AA. Cardiac transplantation with ABO-compatible donors has equivalent long-term survival. Surgery. 2013;154(2):274-81.
Cooper DK. A clinical survey of cardiac transplantation between ABO blood group-incompatible recipients and donors. Transplant Proc. 1990;22(4):1457.
O'Connell JB, Renlund DG, Bristow MR, Hammond EH. Detection of allograft endothelial cells of recipient origin following ABO-compatible, nonidentical cardiac transplantation. Transplantation. 1991;51(2):438-42.
Odegard KC, Laussen PC, Zurakowski D, Hornykewycz SJ, Laussen JC, Hansen DD. Distribution of ABO phenotypes in patients with congenital cardiac defects. Cardiol Young. 2008;18(3):307-10.
Kocher AA, Schlechta B, Ehrlich M, Ploner M, Khazen C, Schuster MP, et al. Effect of ABO blood type matching in cardiac transplant recipients. Transplant Proc. 2001;33(5):2752-4.
Lanza RP, Cooper DK, Barnard CN. Effect of ABO blood-group antigens on long-term survival after cardiac transplantation. N Engl J Med. 1982;307(20):1275-6.
Botha P, Hasan A, Haynes S, Cassidy J, Roe J, Wallis J, et al. Exchange transfusion during extra corporeal membrane oxygenation used as a bridge to ABO-mismatch cardiac transplantation. Ann Thorac Surg. 2006;81(3):1105-7.
Sjögren J, Ljungdahl-Waller F, Senneby E, Ekmehag B, Koul B, Nilsson J. Heart transplantation with ABO-identical versus ABO-compatible cardiac grafts: influence on long-term survival. Scand Cardiovasc J. 2010;44(6):373-9.
Issitt RW, Crook RM, Cross NT, Shaw M, Robertson A, Burch M, et al. Incompatible ABO-plasma exchange and its impact on patient selection in paediatric cardiac transplantation. Perfusion. 2012;27(6):480-5.
Manji JS, Rajotte RV, Koshal A, Manji RA. Increased apoptosis in porcine cardiac xenografts perfused with human ABO plasma containing the anti-B antibody. Xenotransplantation. 2004;11(4):378-9.
Hendriks GF, Wenting GJ, Mochtar B, Bos E, Simoons ML, Balk AH, et al. The influence of ABO blood groups on the incidence of cardiac allograft rejection in males. Transplant Proc. 1989;21(1 Pt 1):803.
McKenzie FN, Tadros N, Stiller C, Keown P, Sinclair N, Kostuk W. Influence of donor-recipient lymphocyte crossmatch and ABO status on rejection risk in cardiac transplantation. Transplant Proc. 1987;19(4):3439-41.
Chae MS, Kim Y, Oh SA, Jeon Y, Choi HJ, Kim YH, et al. Intraoperative Management of a Patient With Impaired Cardiac Function Undergoing Simultaneous ABO-Compatible Liver and ABO-Incompatible Kidney Transplant From 2 Living Donors: A Case Report. Transplant Proc. 2018;50(10):3988-94.
Shumway SJ, Baumgartner WA, Soule LM, Gardner TJ, Reitz BA. Lack of effect of ABO blood-group antigens on survival after cardiac transplantation. N Engl J Med. 1987;317(12):772-3.
Roche SL, Burch M, O'Sullivan J, Wallis J, Parry G, Kirk R, et al. Multicenter experience of ABO-incompatible pediatric cardiac transplantation. Am J Transplant. 2008;8(1):208-15.
Cooper DK, Ye Y, Kehoe M, Niekrasz M, Rolf LL, Jr., Martin M, et al. A novel approach to "neutralization" of preformed antibodies: cardiac allotransplantation across the ABO blood group barrier as a paradigm of discordant transplantation. Transplant Proc. 1992;24(2):566-71.
Irving C, Gennery A, Kirk R. Pushing the boundaries: the current status of ABO-incompatible cardiac transplantation. J Heart Lung Transplant. 2012;31(8):791-6.
Cooper DK, Human PA, Rose AG, Rees J, Keraan M, Reichart B, et al. The role of ABO blood group compatibility in heart transplantation between closely related animal species. An experimental study using the vervet monkey to baboon cardiac xenograft model. J Thorac Cardiovasc Surg. 1989;97(3):447-55.
Gelas T, Hartley J, Mirza DF, Muiesan P, Bowen C, Sharif K. Segmental ABO-incompatible liver graft from a donor after cardiac death in neonatal acute liver failure. Pediatr Transplant. 2012;16(2):E53-7.
Cooper DK, Ye Y, Niekrasz M, Kehoe M, Martin M, Neethling FA, et al. Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection--experience with ABO-incompatible cardiac allografting in the baboon. Transplantation. 1993;56(4):769-77.
Caruana RJ, Zumbro GL, Jr., Hoff RG, Rao RN, Daspit SA. Successful cardiac transplantation across an ABO blood group barrier. Transplantation. 1988;46(3):472-4.
Rexius H, Nyström U, Lorentzon U, Nilsson F, Jeppsson A. The use of ABO compatible non-identical organs for cardiac transplantation: are we treating potential recipients with blood group O fairly? J Heart Lung Transplant. 2001;20(2):207.
Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PloS one. 2010;5(8):e11972.
Jacoub K, Al-Eisawi Z. ABO blood group and skin cancers. Clin Hemorheol Microcirc. 2022;81(4):359-71.
Haberal M, Gülay H, Arslan G, Bilgin N. ABO incompatible kidney transplantation with skin grafting. Transplant Proc. 1989;21(1 Pt 1):781-2.
Haberal M, Gülay H, Arslan G, Sert S, Altunkan S, Bilgin N. ABO-incompatible kidney transplantation with donor-specific skin graft. Ren Fail. 1991;13(2-3):103-10.
Belliere J, Rolland M, Tournier E, Cassaing S, Iriart X, Paul C, et al. Early necrotic skin lesions after a ABO-incompatible kidney transplantation: The threat of Cunninghamella Spp. Transpl Infect Dis. 2019;21(6):e13173.
Tojimbara T, Nakajima I, Kimikawa M, Sato S, Kawase T, Nanmoku K, et al. Hand-assisted laparoscopic splenectomy in ABO-incompatible kidney transplant recipients: a single skin incision technique. Transplant Proc. 2003;35(1):321-2.
Shirai Y, Funada H, Seki T, Morohashi M, Kamimura K. Landing preference of Aedes albopictus (Diptera: Culicidae) on human skin among ABO blood groups, secretors or nonsecretors, and ABH antigens. J Med Entomol. 2004;41(4):796-9.
Haberal M, Tokyay R, Bilgin N. Outcome of donor-specific skin graft is a reliable prognostic sign in ABO-incompatible live-donor renal transplants. Transplant Proc. 1992;24(6):2530-1.
Tursen U, Tiftik EN, Unal S, Gunduz O, Kaya TI, Camdeviren H, et al. Relationship between ABO blood groups and skin cancers. Dermatol Online J. 2005;11(3):44.
Cihan YB, Baykan H, Kavuncuoglu E, Mutlu H, Kucukoglu MB, Ozyurt K, et al. Relationships between skin cancers and blood groups--link between non-melanomas and ABO/Rh factors. Asian Pac J Cancer Prev. 2013;14(7):4199-203.
Lee DH, Jung JY, Oh JH, Lee S, Kim YK, Chung JH. Ultraviolet irradiation modulates ABO blood group antigens in human skin in vivo: possible implication in skin aging. J Dermatol Sci. 2012;66(1):71-3.
Blika S, Ringvold A, Braathen LN, Juel E. ABO-blood groups and D-antigen in simple and capsular glaucoma. Acta Ophthalmol (Copenh). 1984;62(6):1009-13.
Khan MI, Micheal S, Akhtar F, Naveed A, Ahmed A, Qamar R. Association of ABO blood groups with glaucoma in the Pakistani population. Can J Ophthalmol. 2009;44(5):582-6.
Skaik YA. Further considerations in investigating the association of ABO and Rh (D) blood groups with glaucoma (Association of ABO blood groups with glaucoma in the Pakistani population. Vol. 44[5]). Can J Ophthalmol. 2010;45(2):177; author reply 8.
Karimi S, Mehrdel P, Farré-Lladós J, Casals-Terré J. A passive portable microfluidic blood-plasma separator for simultaneous determination of direct and indirect ABO/Rh blood typing. Lab Chip. 2019;19(19):3249-60.
Jager MJ, Völker-Dieben HJ, de Wolff-Rouendaal D, Kakebeeke-Kemme H, D'Amaro J. Possible relation between HLA and ABO type and prognosis of uveal melanoma. Doc Ophthalmol. 1992;82(1-2):43-7.
Harritshøj LH, Nielsen C, Ullum H, Hansen MB, Julian HO. Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy. Acta Ophthalmol. 2014;92(8):783-6.
White LE. Retinal venous occlusion and ABO blood-groups. N Z Med J. 1978;87(606):124-6.
Borella E, Spiezia L, Turatti G, Poretto A, Marobin M, Campello E, et al. ABO blood groups and the risk of retinal vein occlusion. Intern Emerg Med. 2021;16(5):1387-90.
White LE. ABO blood-groups and retinal venous occlusions. N Z Med J. 1980;92(667):213.
Parr JC, White LE. ABO blood-groups and the visual outcome of a retinal venous occlusion. Trans Ophthalmol Soc N Z. 1978;30:19-22.
Teberik K, Eski MT. Association of ABO blood groups and Rh factor with retinal and choroidal thickness. Eur J Ophthalmol. 2019;29(2):234-8.
Posch-Pertl L, List W, Michelitsch M, Pinter-Hausberger S, Posch F, Innauer F, et al. Role of the ABO blood groups as a risk factor for retinal vein occlusion. Ophthalmic Res. 2022.
Pereira E, Felipe S, de Freitas R, Araújo V, Soares P, Ribeiro J, et al. ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms. Microb Pathog. 2022;169:105658.
Shinebaum R. ABO blood group and secretor status in the spondyloarthropathies. FEMS Microbiol Immunol. 1989;1(6-7):389-95.
Lampalo M, Jukić I, Bingulac-Popović J, Safić Stanić H, Ferara N, Popović-Grle S. ABO blood group genotypes and ventilatory dysfunction in patients with allergic and nonallergic asthma. Med Glas (Zenica). 2020;17(2):369-74.
Padhi S, Suvankar S, Dash D, Panda VK, Pati A, Panigrahi J, et al. ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population. Transfus Clin Biol. 2020;27(4):253-8.
Koregol AC, Raghavendra M, Nainegali S, Kalburgi N, Varma S. ABO blood groups and Rhesus factor: an exploring link to periodontal diseases. Indian J Dent Res. 2010;21(3):364-8.
Bhattacharjee S, Banerjee M, Pal R. ABO blood groups and severe outcomes in COVID-19: A meta-analysis. Postgrad Med J. 2020.
Bhattacharjee S, Banerjee M, Pal R. ABO blood groups and severe outcomes in COVID-19: A meta-analysis. Postgrad Med J. 2022;98(e2):e136-e7.
Bullerdiek J, Reisinger E, Rommel B, Dotzauer A. ABO blood groups and the risk of SARS-CoV-2 infection. Protoplasma. 2022:1-15.
Pałgan K, Bartuzi Z, Chrzaniecka E. ABO blood groups, Rhesus factor, and anaphylactic reactions due to Hymenoptera stings. Ann Agric Environ Med. 2017;24(3):428-30.
Schachtner T, Stein M, Reinke P. ABO desensitization affects cellular immunity and infection control after renal transplantation. Transpl Int. 2015;28(10):1179-94.
Segev DL, Simpkins CE, Warren DS, King KE, Shirey RS, Maley WR, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant. 2005;5(10):2570-5.
Ali T, Broering D, Aleid H, Brockmann J, Alhumaidan H, Hammad E, et al. ABO incompatible kidney transplantation: the Saudi experience. Saudi J Kidney Dis Transpl. 2019;30(3):655-62.
Mathew A, Vignesh Balaji E, Pai SRK, Kishore A, Pai V, Chandrashekar KS. ABO phenotype and SARS-CoV-2 infection: Is there any correlation? Infect Genet Evol. 2021;90:104751.
Skripal IG. ABO system of blood groups in people and their resistance to certain infectious diseases (prognosis). Mikrobiol Z. 1996;58(2):102-8.
de Weerd AE, Betjes MGH. ABO-Incompatible Kidney Transplant Outcomes: A Meta-Analysis. Clin J Am Soc Nephrol. 2018;13(8):1234-43.
Morath C, Zeier M, Döhler B, Opelz G, Süsal C. ABO-Incompatible Kidney Transplantation. Front Immunol. 2017;8:234.
Kosoku A, Uchida J, Shimada H, Kabei K, Nishide S, Iwai T, et al. ABO-Incompatible Kidney Transplantation After Bone Marrow Transplantation: A Case Report. Transplant Proc. 2020;52(9):2754-7.
Kosoku A, Uchida J, Nishide S, Kabei K, Shimada H, Iwai T, et al. ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan. PloS one. 2018;13(12):e0208638.
Geyer M, Fischer KG, Drognitz O, Walz G, Pisarski P, Wilpert J. ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab - insights and uncertainties. Contrib Nephrol. 2009;162:47-60.
Shah Y, Almeshari K, Broering D, Aleid H, Brockmann J, Alhumaidan H, et al. ABO-Incompatible Kidney Transplantation: Low Rates of Infectious Complications and Excellent Patient Survival. Transplant Proc. 2019;51(2):512-6.
Toso C, Al-Qahtani M, Alsaif FA, Bigam DL, Meeberg GA, James Shapiro AM, et al. ABO-incompatible liver transplantation for critically ill adult patients. Transpl Int. 2007;20(8):675-81.
Uribe M, Buckel E, Ferrario M, Segovia R, González G, Hunter B, et al. ABO-incompatible liver transplantation: a new therapeutic option for patients with acute liver failure in Chile. Transplant Proc. 2005;37(3):1567-8.
Cen M, Wang R, Kong W, Deng H, Lei W, Chen J. ABO-incompatible living kidney transplantation. Clin Transplant. 2020;34(9):e14050.
Okumi M, Toki D, Nozaki T, Shimizu T, Shirakawa H, Omoto K, et al. ABO-Incompatible Living Kidney Transplants: Evolution of Outcomes and Immunosuppressive Management. Am J Transplant. 2016;16(3):886-96.
Shishido S, Asanuma H, Tajima E, Hoshinaga K, Ogawa O, Hasegawa A, et al. ABO-incompatible living-donor kidney transplantation in children. Transplantation. 2001;72(6):1037-42.
Fernández Rivera C, Calvo Rodríguez M, López Muñíz A, Ferreiro Hermida T, Seijo Bestilleiro R, Andón Saavedra C, et al. ABO-incompatible living-donor kidney transplantation: Study of 48 patients after desensitisation. Nefrologia (Engl Ed). 2019;39(6):612-22.
Schiffer M, Kielstein JT. ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier. Korean J Hematol. 2011;46(3):164-8.
Hafeeq B, Aziz F, Narayanan S, Aboobacker IN, Gopinathan JC, Narayanan R, et al. ABO-incompatible transplantation without conventional induction immunosuppression (IL-2RB or depleting agents). Saudi J Kidney Dis Transpl. 2020;31(3):572-81.
Peruhova M, Georgieva V, Yurukova N, Sekulovska M, Panayotova G, Mihova A, et al. ABO-nonidentical liver transplantation from a deceased donor and clinical outcomes following antibody rebound: A case report. World J Transplant. 2020;10(5):138-46.
Ronchetti F, Villa MP, Ronchetti R, Bonci E, Latini L, Pascone R, et al. ABO/Secretor genetic complex and susceptibility to asthma in childhood. Eur Respir J. 2001;17(6):1236-8.
Ko Y, Kim JY, Kim SH, Kim DH, Lim SJ, Shin S, et al. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations. Ann Transplant. 2020;25:e927420.
Komal A, Noreen M, Akhtar J, Imran M, Jamal M, Atif M, et al. Analyses of ABO blood groups with susceptibility and symptomatic variations of COVID-19 infection, a questionnaire-based survey. Apmis. 2021;129(10):579-86.
Fan Q, Zhang W, Li B, Li DJ, Zhang J, Zhao F. Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan. Front Cell Infect Microbiol. 2020;10:404.
Liu Y, Häussinger L, Steinacker JM, Dinse-Lambracht A. Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution. Epidemiol Infect. 2021;149:e19.
Rana R, Ranjan V, Kumar N. Association of ABO and Rh Blood Group in Susceptibility, Severity, and Mortality of Coronavirus Disease 2019: A Hospital-Based Study From Delhi, India. Front Cell Infect Microbiol. 2021;11:767771.
Ganguly S, Sarkar P, Chatterjee D, Bandyopadhyay AR. Association of ABO blood group polymorphism and tuberculosis: A study on Bengalee Hindu caste population, West Bengal, India. Indian J Tuberc. 2016;63(4):242-4.
Li J, Song X, Bu X, Wan Y. The association of ABO blood types with host susceptibility to hemorrhagic fever with renal syndrome. Epidemiol Infect. 2021;149:1-14.
Kuo KC, Kuo HC, Huang LT, Lin CS, Yang SN. The clinical implications of ABO blood groups in Pseudomonas aeruginosa sepsis in children. J Microbiol Immunol Infect. 2013;46(2):109-14.
Baek CH, Kim H, Yang WS, Han DJ, Park SK. Clinical significance of isoagglutinin titre with the current desensitization protocol in ABO-incompatible kidney transplantation. Nephrology (Carlton). 2019;24(6):654-60.
Fry AE, Griffiths MJ, Auburn S, Diakite M, Forton JT, Green A, et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet. 2008;17(4):567-76.
Pai GP, Dayakar MM, Shaila M, Dayakar A. Correlation between "ABO" blood group phenotypes and periodontal disease: Prevalence in south Kanara district, Karnataka state, India. J Indian Soc Periodontol. 2012;16(4):519-23.
Maritati F, Bini C, Cuna V, Tondolo F, Lerario S, Grandinetti V, et al. Current Perspectives in ABO-Incompatible Kidney Transplant. J Inflamm Res. 2022;15:3095-103.
Shishido S, Hasegawa A. Current status of ABO-incompatible kidney transplantation in children. Pediatr Transplant. 2005;9(2):148-54.
Egawa H, Ohdan H, Saito K. Current Status of ABO-incompatible Liver Transplantation. Transplantation. 2022.
Chung BH, Hong YA, Sun IO, Piao SG, Kim JI, Moon IS, et al. Determination of rituximab dose according to immunologic risk in ABO-incompatible kidney transplantation. Ren Fail. 2012;34(8):974-9.
Lentine KL, Axelrod D, Klein C, Simpkins C, Xiao H, Schnitzler MA, et al. Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation. 2014;98(1):54-65.
Yazawa M, Sasaki H, Sakurai Y, Kudo H, Nakazawa R, Chikaraishi T, et al. Early post-transplant diagnosis of cytomegalovirus esophagitis in an ABO-incompatible kidney transplant recipients: A case report. Transpl Infect Dis. 2018;20(2):e12827.
Thukral S, Shinde N, Ray DS. Effect of Different Rituximab Doses on B Cell Count, Anti-A/B Antibody Titer, Graft Function, and Infectious Complications in ABO-Incompatible Renal Transplantation: A Prospective Study. Transplant Proc. 2021;53(3):970-5.
Sakai H, Tanaka Y, Tazawa H, Shimizu S, Verma S, Ohira M, et al. Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation. Transplant Direct. 2017;3(6):e164.
Lee J, Lee JG, Kim S, Song SH, Kim BS, Kim HO, et al. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation. Nephrol Dial Transplant. 2016;31(6):1013-21.
Kim BW, Park YK, Kim YB, Wang HJ, Kim MW. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea. Transplant Proc. 2008;40(10):3772-7.
Franchini M, Bonfanti C. Evolutionary aspects of ABO blood group in humans. Clin Chim Acta. 2015;444:66-71.
Melexopoulou C, Marinaki S, Liapis G, Skalioti C, Gavalaki M, Zavos G, et al. Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center. World J Transplant. 2015;5(4):329-37.
Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Kondo T, et al. Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid. Transplant Proc. 2004;36(7):2175-7.
Li PC, Thorat A, Hsu SC, Poon KS, Yang HR, Chen TH, et al. Extracorporeal Membrane Oxygenation Support for Rituximab-Induced Acute Respiratory Distress Syndrome in an ABO-Incompatible Living Donor Liver Transplant Recipient: Successful Management of a Rare Complication and a Review of the Literature. Ann Transplant. 2017;22:463-7.
Rosdahl N, Svejgaard A. HLA types and ABO blood groups in patients with infectious mononucleosis. Tissue Antigens. 1979;13(3):223-7.
Choi BH, Cho HK, Jung JH, Choi JY, Shin S, Kim YH, et al. How to reduce lethal infectious complications in ABO-incompatible kidney transplantation. Transplant Proc. 2015;47(3):653-9.
Abegaz SB. Human ABO Blood Groups and Their Associations with Different Diseases. Biomed Res Int. 2021;2021:6629060.
Aguiar DC, Barros VL, Pereira WL, Loiola Rdo S, Matos GC, Valsecchi J, et al. Immunodetection of Helicobacter sp. and the associated expression of ABO blood group antigens in the gastric mucosa of captive and free-living New World primates in the Amazon region. Mem Inst Oswaldo Cruz. 2011;106(8):936-41.
Minchenko ZM, Kustovska AD, Prymachenko SV, Dmytrenko OO, Liubarets TF, Shlyahtichenko TY, et al. IMMUNOGENETIC AND PHARMACOCHEMICAL CHARACTERIZATION OF THE ABO SYSTEM GLYCOPROTEIN PROPERTIES AS CRITERIA OF INDIVIDUAL SENSITIVITY TO ANTITUMOR AGENT BORTEZOMIB IN THE PLASMA CELL MYELOMA PATIENTS. Probl Radiac Med Radiobiol. 2019;24:426-38.
Hsieh CE, Yang Y, Lin KH, Chen CC, Ko CJ, Hsu YL, et al. Impact of Positive Donor-Specific HLA Antibodies Crossmatch on Graft Survival in ABO-Incompatible Liver-Kidney Transplantation: A Case Report. Transplant Proc. 2018;50(10):4008-11.
Kaihara S, Okamoto M, Akioka K, Ogino S, Higuchi A, Kadotani Y, et al. Improved graft survival in ABO-incompatible living donor kidney transplantation. Transplant Proc. 2005;37(4):1804-5.
Habicht A, Bröker V, Blume C, Lorenzen J, Schiffer M, Richter N, et al. Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. Nephrol Dial Transplant. 2011;26(12):4124-31.
Hirzel C, Projer L, Atkinson A, Surial B, Mueller NJ, Manuel O, et al. Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study. Transplantation. 2022;106(9):1875-83.
Grim SA, Pham T, Thielke J, Sankary H, Oberholzer J, Benedetti E, et al. Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant. 2007;21(5):628-32.
Tanabe K, Takahashi K, Tokumoto T, Ishikawa N, Oshima T, Kanematsu A, et al. Infectious complications in ABO-incompatible living donor kidney transplantation: a single center experience. Transplant Proc. 1998;30(7):3130-2.
Bubnov YI, Turkova TI, Eremyan AV. Influence of infectious diseases on hereditary polymorphism with respect to the blood groups of the ABO system. Sov Genet. 1974;9(1):105-8.
Genberg H, Kumlien G, Wennberg L, Tydén G. Isoagglutinin adsorption in ABO-incompatible transplantation. Transfus Apher Sci. 2010;43(2):231-5.
Rivera CF, Rodriguez MC, Hermida TF, Jarrin DA, Muñiz AL, Saavedra CA, et al. Isoagglutinin Titers in ABO-Incompatible Kidney Transplant. Transplant Proc. 2021;53(9):2675-7.
Ishikawa N, Yagisawa T, Kimura T, Sakuma Y, Fujiwara T, Nukui A, et al. Kidney transplantation of living unrelated and ABO-incompatible donor-recipient combinations. Transplant Proc. 2013;45(3):1242-4.
Langhorst C, Ganner A, Schneider J, Prager EP, Walz G, Pisarski P, et al. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report. Transplant Proc. 2021;53(3):848-55.
Wilpert J, Fischer KG, Pisarski P, Wiech T, Daskalakis M, Ziegler A, et al. Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis. Nephrol Dial Transplant. 2010;25(11):3778-86.
Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation. 1998;65(2):224-8.
Banner NR, Rose ML, Cummins D, de Silva M, Pottle A, Lyster H, et al. Management of an ABO-incompatible lung transplant. Am J Transplant. 2004;4(7):1192-6.
Hourmant M, Figueres L, Gicquel A, Kimmel C, Garandeau C. New rules of ABO-compatibility in kidney transplantation. Transfus Clin Biol. 2019;26(3):180-3.
Shinebaum R, Blackwell CC, Forster PJ, Hurst NP, Weir DM, Nuki G. Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed). 1987;294(6566):208-10.
Zschiedrich S, Jänigen B, Dimova D, Neumann A, Seidl M, Hils S, et al. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience. Nephrol Dial Transplant. 2016;31(4):663-71.
Choi BH, Han DJ. Ongoing higher infection rate in ABO-incompatible kidney transplant recipient: is it a serious problem? A single-center experience. Ann Surg Treat Res. 2016;91(1):37-44.
Speer C, Kälble F, Nusshag C, Pego da Silva L, Schaier M, Becker LE, et al. Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption - a retrospective study. Transpl Int. 2019;32(12):1286-96.
Kakuta Y, Okumi M, Unagami K, Iizuka J, Takagi T, Ishida H, et al. Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: A single-center Japanese cohort study. Clin Transplant. 2019;33(6):e13591.
Sethi SK, Bansal SB, Wadhwani N, Tiwari A, Arora D, Sharma R, et al. Pediatric ABO-incompatible kidney transplantation: Evolving with the advancing apheresis technology: A single-center experience. Pediatr Transplant. 2018;22(3):e13138.
Pandey P, Kumari S, Mandal S, Setya D, Kumar P. A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India. Transfus Clin Biol. 2022;29(3):213-8.
Rosenstein IJ, Hazlehurst GR, Burroughs AK, Epstein O, Sherlock S, Brumfitt W. Recurrent bacteriuria and primary biliary cirrhosis: ABO blood group, P1 blood group, and secretor status. J Clin Pathol. 1984;37(9):1055-8.
Shilo R, Gutman R, Ascari D, Schwartz J. Reevaluation of the polyvinylpyrrolidone sedimentation test in the diagnosis of ABO hemolytic disease of the newborn. Vox Sang. 1976;31(1 suppl):16-24.
Franchini M, Mengoli C, Lippi G. Relationship between ABO blood group and pregnancy complications: a systematic literature analysis. Blood Transfus. 2016;14(5):441-8.
Blackwell CC. The role of ABO blood groups and secretor status in host defences. FEMS Microbiol Immunol. 1989;1(6-7):341-9.
Geisel J, Steuer MK, Ko HL, Beuth J. The role of ABO blood groups in infections induced by Staphylococcus saprophyticus and Pseudomonas aeruginosa. Zentralbl Bakteriol. 1995;282(4):427-30.
Ray JG, Park AL. SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study. BMJ Open. 2022;12(7):e059944.
Alessa MY, Aledili FJ, Alnasser AA, Aldharman SS, Al Dehailan AM, Abuseer HO, et al. The Side Effects of COVID-19 Vaccines and Its Association With ABO Blood Type Among the General Surgeons in Saudi Arabia. Cureus. 2022;14(3):e23628.
Böhmig GA, Farkas AM, Eskandary F, Wekerle T. Strategies to overcome the ABO barrier in kidney transplantation. Nat Rev Nephrol. 2015;11(12):732-47.
Song SH, Lee J, Kim BS, Kim S, Lee JG, Jeong HJ, et al. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center Clin Nephrol. 2017;88(9):117-23.
Fischer MB, Wolfram W, Binder CJ, Böhmig GA, Wahrmann M, Eibl MM, et al. Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable Immunodeficiency. Front Immunol. 2015;6:211.
Tobian AA, Shirey RS, Montgomery RA, Tisch DJ, Ness PM, King KE. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion. 2009;49(6):1248-54.
Opelz G, Morath C, Süsal C, Tran TH, Zeier M, Döhler B. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers. Transplantation. 2015;99(2):400-4.
Yin S, Tan Q, Yang Y, Zhang F, Song T, Fan Y, et al. Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation. Chin Med J (Engl). 2022.
Ishikawa N, Yagisawa T, Sakuma Y, Fujiwara T, Nukui A, Yashi M, et al. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations. Transplant Proc. 2008;40(7):2292-3.
Haidinger M, Schmaldienst S, Körmöczi G, Regele H, Soleiman A, Schwartz D, et al. Vienna experience of ABO-incompatible living-donor kidney transplantation. Wien Klin Wochenschr. 2009;121(7-8):247-55.
Dabelsteen E. ABO blood group antigens in oral mucosa. What is new? J Oral Pathol Med. 2002;31(2):65-70.
Singh A, Purohit BM. ABO Blood Groups and Its Association with Oral Cancer, Oral Potentially Malignant Disorders and Oral Submucous Fibrosis- A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2021;22(6):1703-12.
Bhateja S, Arora G. ABO blood groups and oral premalignancies: A clinical study in selected Indian population. Indian J Cancer. 2014;51(3):219-21.
Mortazavi H, Hajian S, Fadavi E, Sabour S, Baharvand M, Bakhtiari S. ABO blood groups in oral cancer: a first case-control study in a defined group of Iranian patients. Asian Pac J Cancer Prev. 2014;15(3):1415-8.
Dabelsteen E, Gao S. ABO blood-group antigens in oral cancer. J Dent Res. 2005;84(1):21-8.
Rai P, Acharya S, Hallikeri K. Assessment of ABO blood grouping and secretor status in the saliva of the patients with oral potentially malignant disorders. J Oral Maxillofac Pathol. 2015;19(2):164-9.
Ramesh G, Katiyar A, Raj A, Kumar A, Nagarajappa R, Pandey A. Assessment of relationship of ABO blood groups among tobacco induced oral cancer patients of Kanpur Population, Uttar Pradesh. J Exp Ther Oncol. 2017;12(2):129-35.
Verma P, Kumar A, Dixit S, Mohan K, Gupta N, Mandal G. Assessment of Relationship of ABO Blood Groups in Oral Cancer Patients - A Retrospective Study. Ann Maxillofac Surg. 2021;11(1):80-5.
Sivanand N, Junaid M, Sivapathasundaram B, Ramanathan M, Sailer HF, Nijesh JE, et al. Association between ABO, Rh blood groups, lip and dermatoglyphic patterns, and nonsyndromic oral clefts: A case-control study. J Indian Soc Pedod Prev Dent. 2021;39(1):9-15.
Noda H, Yokota M, Tatsumi S, Sugiyama S. Determination of ABO blood grouping from human oral squamous epithelium by the highly sensitive immunohistochemical staining method EnVision+. J Forensic Sci. 2002;47(2):341-4.
Cerović R, Juretić M, Balen S, Belusić M, Caser L, Rogić M. Examining the presence of ABO(H) antigens of blood types in the saliva of patients with oral cancer. Coll Antropol. 2008;32(2):509-12.
Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Liu CJ, et al. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer. 2004;109(2):230-7.
Pruissen DM, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ, Algra A. Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin. J Neurol. 2007;254(12):1660-5.
Gao S, Bennett EP, Reibel J, Chen X, Christensen ME, Krogdahl A, et al. Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma--genotypic and phenotypic characterization. Apmis. 2004;112(1):11-20.
Huibregtse IL, Marietta EV, Rashtak S, Koning F, Rottiers P, David CS, et al. Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol. 2009;183(4):2390-6.
Shishodia NP, Anekar J, Raj AC, Jhugroo C, Divakar DD, Alshehri SZ, et al. Insight on the relationship of ABO blood grouping associated with oral premalignant lesions, conditions and inherited oral cancer syndromes. J Exp Ther Oncol. 2019;13(1):59-63.
Guimarães DA, dos Santos MS, Gomes KB, van der Bom JG, Rios DR, Cardoso J, et al. Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women. Menopause. 2012;19(3):339-45.
Gopal Reddy VK, Moon NJ, Sharva V, Reddy EK, Chandralkala S. Is there an association between oral submucous fibrosis and ABO blood grouping? J Cancer Res Ther. 2016;12(1):126-30.
Blondon M, Wiggins KL, Harrington LB, Psaty BM, Smith NL. Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy. J Thromb Haemost. 2013;11(8):1617-9.
Cao H, Wu R, Han M, Caldwell PHY, Liu JP. Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility: A systematic review of randomized controlled trials. PloS one. 2017;12(7):e0180746.
Mohamed ABO, Al-Ama N, Al Kreathy H, Ahmed KHB, Al Amri T, Harakeh S, et al. Oral Contraceptive Types in Relation to ABO Blood Groups Among Saudi Women of Different Reproductive Age Groups and Impact on Venous Thromboembolism. Clin Appl Thromb Hemost. 2020;26:1076029620966051.
Ambrus JL. Oral contraceptives, ABO blood types and thromboembolism. Cmaj. 2013;185(17):1526.
Sharma SK, Kumar S, Agrawal N, Mishra P, Seth T, Mahapatra M. Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report. Indian J Hematol Blood Transfus. 2015;31(2):317-8.
Noujeim Z, Nasr L, Hajj R, El-Outa A. Prevalence of recurrent oral ulcers and association with ABO/Rh group systems in a Lebanese sample. An Bras Dermatol. 2022;97(3):390-4.
Mahalakshmi IP, Sinha P, Nagaraj T, Okade D, Nonitha S, Veerabasaivaiah BT. Relationship between ABO blood group and Rh factor with oral potentially malignant disorder. J Oral Maxillofac Pathol. 2022;26(1):57-9.
Jaleel BF, Nagarajappa R. Relationship between ABO blood groups and oral cancer. Indian J Dent Res. 2012;23(1):7-10.
Topno N, Narvey VP, Jain AK. The Correlation of Allergic Rhinitis with ABO Phenotype. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 3):1827-31.
Dahalan NH, Tuan Din SA, Mohamad SMB. Association of ABO blood groups with allergic diseases: a scoping review. BMJ Open. 2020;10(2):e029559.
el-Mehairy MM, el-Tarabishi N. The correlation between ABO blood groups and allergic disorders. Ann Allergy. 1966;24(7):366-8.
